ES2078462T3 - Esteres de castanoespermina anti-herpes. - Google Patents

Esteres de castanoespermina anti-herpes.

Info

Publication number
ES2078462T3
ES2078462T3 ES91311275T ES91311275T ES2078462T3 ES 2078462 T3 ES2078462 T3 ES 2078462T3 ES 91311275 T ES91311275 T ES 91311275T ES 91311275 T ES91311275 T ES 91311275T ES 2078462 T3 ES2078462 T3 ES 2078462T3
Authority
ES
Spain
Prior art keywords
herpes
castanoespermina
esters
esteres
castan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91311275T
Other languages
English (en)
Inventor
A Stanley Tyms
Paul Saiho Liu
Debra L Taylor
Prasad S Sunkara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2078462T3 publication Critical patent/ES2078462T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Dental Preparations (AREA)

Abstract

ESTERES CASTANOSPERMINAS ACTIVOS EN EL TRATAMIENTO DE LAS INFECCIONES VIRALES HERPES.
ES91311275T 1990-12-18 1991-12-04 Esteres de castanoespermina anti-herpes. Expired - Lifetime ES2078462T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909027433A GB9027433D0 (en) 1990-12-18 1990-12-18 Anti-herpes castanospermine esters

Publications (1)

Publication Number Publication Date
ES2078462T3 true ES2078462T3 (es) 1995-12-16

Family

ID=10687190

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91311275T Expired - Lifetime ES2078462T3 (es) 1990-12-18 1991-12-04 Esteres de castanoespermina anti-herpes.

Country Status (20)

Country Link
US (1) US5385911A (es)
EP (1) EP0492841B1 (es)
JP (1) JPH04342587A (es)
KR (1) KR100192642B1 (es)
AT (1) ATE126435T1 (es)
AU (1) AU643098B2 (es)
CA (1) CA2057821A1 (es)
DE (1) DE69112192T2 (es)
DK (1) DK0492841T3 (es)
ES (1) ES2078462T3 (es)
FI (1) FI915929A7 (es)
GB (1) GB9027433D0 (es)
GR (1) GR3017152T3 (es)
HU (1) HU210257B (es)
IE (1) IE914400A1 (es)
IL (1) IL100233A (es)
NO (1) NO914986D0 (es)
NZ (1) NZ240976A (es)
PT (1) PT99835B (es)
ZA (1) ZA919808B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466714A (en) * 1987-12-31 1995-11-14 Research Foundation For Mental Health Hygiene, Inc. Spermicidal and cytocidal fatty acid compositions
US5959111A (en) * 1997-05-22 1999-09-28 Hoechst Marion Roussel, Inc. Process for preparing 6-0-monoesters of castanospermine
AU2001234596A1 (en) * 2000-01-28 2001-08-07 Timothy M Block Use of castanospermine and substituted-castanospermine compounds for treating hepatitis virus infections
GB0110832D0 (en) * 2001-05-03 2001-06-27 Virogen Ltd Antiviral compounds
GB0116643D0 (en) * 2001-07-09 2001-08-29 Virogen Ltd Antiviral compounds
US7930711B2 (en) * 2003-03-06 2011-04-19 Wegener Communications, Inc. Apparatus and method for addressing control in a network for distributed data
JP2008515816A (ja) * 2004-10-06 2008-05-15 ミジェニックス インコーポレイテッド カスタノスペルミンを含有する、併用抗ウイルス組成物およびその使用方法
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20080138351A1 (en) * 2006-08-02 2008-06-12 United Therapeutics Corporation Liposome treatment of viral infections
US20090252785A1 (en) * 2008-03-26 2009-10-08 University Of Oxford Endoplasmic reticulum targeting liposomes
CN102427804A (zh) * 2009-03-27 2012-04-25 牛津大学之校长及学者 降低胆固醇水平的脂质体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760079A (en) * 1983-01-10 1988-07-26 Baltech, Inc. Treatment of diseases caused by herpes viruses
US4628063A (en) * 1984-03-08 1986-12-09 Dana P. Brigham Antiviral pharmaceutical preparations and methods for their use
US4800081A (en) * 1984-04-18 1989-01-24 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4782065A (en) * 1984-04-18 1988-11-01 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
JPS61227566A (ja) * 1985-04-01 1986-10-09 Fujisawa Pharmaceut Co Ltd スワインソニンおよび関連化合物の合成法
US4751236A (en) * 1987-05-20 1988-06-14 Avihou Mishniot Method for treating genital herpes
US5004746A (en) * 1987-09-29 1991-04-02 Merrell Dow Pharmaceuticals Inc. Anti-retroviral castanospermine esters
US5017563A (en) * 1988-06-23 1991-05-21 Merrell Dow Pharmaceuticals Inc. Castanospermine esters and glycosides

Also Published As

Publication number Publication date
AU643098B2 (en) 1993-11-04
NZ240976A (en) 1997-03-24
GR3017152T3 (en) 1995-11-30
ZA919808B (en) 1992-09-30
DE69112192D1 (de) 1995-09-21
IL100233A0 (en) 1992-09-06
PT99835B (pt) 1999-06-30
HU913989D0 (en) 1992-03-30
IL100233A (en) 1996-03-31
DK0492841T3 (da) 1995-09-18
FI915929L (fi) 1992-06-19
US5385911A (en) 1995-01-31
FI915929A7 (fi) 1992-06-19
KR100192642B1 (ko) 1999-06-15
KR920011488A (ko) 1992-07-24
JPH04342587A (ja) 1992-11-30
IE914400A1 (en) 1992-07-01
EP0492841A1 (en) 1992-07-01
HUT59924A (en) 1992-07-28
EP0492841B1 (en) 1995-08-16
FI915929A0 (fi) 1991-12-17
CA2057821A1 (en) 1992-06-19
DE69112192T2 (de) 1996-04-04
NO914986D0 (no) 1991-12-17
HU210257B (en) 1995-03-28
ATE126435T1 (de) 1995-09-15
PT99835A (pt) 1992-12-31
AU8964191A (en) 1992-06-25
GB9027433D0 (en) 1991-02-06

Similar Documents

Publication Publication Date Title
FI981591A7 (fi) AIDS:n hoidossa käyttökelpoisia HIV-proteaasi-inhibiittoreita
IT8847858A0 (it) Agenti per la profilassi e la terapia di infezioni retrovirali
BG98902A (bg) Имидазолови производни и тяхната употреба като инхибитори на цитокин
ES2186667T3 (es) Analogos de nucleosidos de 1,3-oxatiolano.
OA08724A (fr) Treatment of human viral infections by dsRNA combined with viral inhibitors.
ES2138969T3 (es) Combinacion de nucleosidos antivirales.
FI895064A7 (fi) Syklosporiinia sisältäviä koostumuksia silmätulehdusten hoitoon
MX9101035A (es) Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene
IT1237999B (it) Trattamento di malattie associate ad infezioni di hiv
FI925871L (fi) Menetelmä terapeuttisesti aktiivisten fenyyliguanidiinijohdannaisten valmistamiseksi
DK0492841T3 (da) Anti-herpes-castanosperminestere
ITMI910071A1 (it) Inseminazione di nuvole
ITRM910621A0 (it) Procedimento per la fabbricazione di transistori con struttura gate -isolante -semiconduttore.
EP0453247A3 (en) Anti-viral compounds
DE68914809D1 (de) Antivirale Wirkstoffe.
DE59106398D1 (de) Oligophosphate mit antiviraler Wirkung.
IT8720800A0 (it) Composto attivo nella terapia carciovascolare.
ITRM920063V0 (it) Il gioco del pentathlon militare
ATE55251T1 (de) Arzneimittel mit einem 6-substituierten adenosin als aktives bestandteil.
NO903568D0 (no) Utnyttbare energikilder paa kjoeretoeyer.
KR930020200U (ko) 능동형 자동 초점장치를 위한 측거장치
MX9102245A (es) Combinaciones de compuestos vainilloides y compuestos antivirales de nucleosido para el tratamiento de infecciones de herpes
ITLI920008U1 (it) Gioco del totovolley
ITSV950002U1 (it) Apparecchio elettrico - il gioco del mister di calcio
DK97192D0 (da) Lysindfald i gavl paa ovenlys

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 492841

Country of ref document: ES